David G. Hassall

2.9k citations

34 papers · 2.1k indexed · h-index 21

Biochemistry top 5%
Endocrinology, Diabetes and Metabolism top 5%
Biochemistry top 5%
Physiology top 5%
- Adipose Tissue and Metabolism 4
Cardiology and Cardiovascular Medicine top 5%
- Antiplatelet Therapy and Cardiovascular Diseases 6
- Cardiovascular Disease and Adiposity 2
Surgery
- Cholesterol and Lipid Metabolism 7
- Lipoproteins and Cardiovascular Health 5
Molecular Biology
- Peroxisome Proliferator-Activated Receptors 7
Immunology
- Atherosclerosis and Cardiovascular Diseases 5
Immunology and Allergy
- Cell Adhesion Molecules Research 3

Co-authors: K. Richard Bruckdorfer Philip M. Bath R. F. G. Booth James S. Owen A. M. Gladwin Richard Palmer J. F. MARTIN Julian E. Beesley
Cited by: Biochemistry Endocrinology, Diabetes and Metabolism
Journals: Journal of Biological Chemistry (1 paper)Advanced Drug Delivery Reviews (1 paper)Biochemical Journal (3 papers)
Partner nations: United Kingdom United States France

In The Last Decade

David G. Hassall

33 papers receiving 2.0k citations

Peers

Countries citing papers authored by David G. Hassall

Since Specialization

Citations

This map shows the geographic impact of David G. Hassall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David G. Hassall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David G. Hassall more than expected).

Fields of papers citing papers by David G. Hassall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David G. Hassall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David G. Hassall. The network helps show where David G. Hassall may publish in the future.

Co-authorship network

The 25 scholars most cited alongside David G. Hassall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David G. Hassall Line = papers co-authored together David G. Hassall links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A new, highly selective murine peroxisome proliferator‐activated receptor δ agonist increases responsiveness to thermogenic stimuli and glucose uptake in skeletal muscle in obese mice Diabetes Obesity and Metabolism ·Robert A. Ngala,Claire J. Stocker,Anirban Roy,David C. Hislop,Edward T. Wargent,Rhonda C. Bell,David G. Hassall,John D. Harling,Andrew N. Billin,Timothy M. Willson,Jonathan R.S. Arch,Michael A. Cawthorne	2011	23
2	Challenges in inhaled product development and opportunities for open innovation Advanced Drug Delivery Reviews ·Ben Forbes,Bahman Asgharian,Lea Ann Dailey,Douglas Ferguson,Per Gerde,Mark Gumbleton,Lena Gustavsson,Colin Hardy,David G. Hassall,Rhys Jones,Ruth Lock,Janet Maas,Tim McGovern,Gary R. Pitcairn,Graham Somers,Ron Wolff	2010	94
3	Triglyceride:High-Density Lipoprotein Cholesterol Effects in Healthy Subjects Administered a Peroxisome Proliferator Activated Receptor δ Agonist Arteriosclerosis Thrombosis and Vascular Biology ·Dennis L. Sprecher,Christine Massien,Greg Pearce,Andrew N. Billin,Itay Perlstein,Timothy M. Willson,David G. Hassall,Nicolas Ancellin,Scott D. Patterson,David C. Lobe,Tony G. Johnson	2006	164
4	Diverging regulation of pyruvate dehydrogenase kinase isoform gene expression in cultured human muscle cells FEBS Journal ·Emily L. Abbot,James G. McCormack,Christine Reynet,David G. Hassall,Kevin W. Buchan,Stephen J. Yeaman	2005	79
5	Molecular Identification of High and Low Affinity Receptors for Nicotinic Acid Journal of Biological Chemistry ·Alan Wise,Steven M. Foord,Neil J. Fraser,Ashley Barnes,Nabil A. Elshourbagy,Michelle M. Eilert,Diane M. Ignar,Paul R. Murdock,Klaudia Steplewski,Andrew R. Green,Andrew J. Brown,Simon J. Dowell,Philip Szekeres,David G. Hassall,Fiona H. Marshall,Shelagh Wilson,Nicholas B. Pike	2003	440
6	Gene therapy for atherosclerosis: A comparative study of adeno-associated virus (AAV) and conventional plasmid vectors encoding human apolipopoprotein E (apoE) cDNAs Atherosclerosis ·P.T. Athanasopoulos,Matthew G. Dunckley,David G. Hassall,Stewart A. Fabb,Aristides D. Tagalakis,S. Shepelmann,J. Owen,J.G. Dickson	1999	1
7	Apolipoprotein E and regulation of cytokine-induced cell adhesion molecule expression in endothelial cells Atherosclerosis ·Anita K. Stannard,David Riddell,Nicholas J. Bradley,David G. Hassall,Annette Graham,James S. Owen	1998	18
8	Impaired mobilisation of cholesterol from stored cholesteryl esters in human (THP-1) macrophages Atherosclerosis ·Annette Graham,Anthony D.R. Angell,Catherine A. Jepson,Stephen J. Yeaman,David G. Hassall	1996	36
9	Changes in free cholesterol content, measured by filipin fluorescence and flow cytometry, correlate with changes in cholesterol biosynthesis in THP‐1 macrophages Cytometry ·David G. Hassall,Annette Graham	1995	20
10	Human serum resistant Trypanosoma brucei rhodesiense accumulates similar amounts of fluorescently-labelled trypanolytic human HDL3 particles as human serum sensitive T.b. brucei Molecular and Biochemical Parasitology ·Patrick Lorenz,James S. Owen,David G. Hassall	1995	10
11	5-[6-1 -(Cyclohexyl-1 H-tetrazol-5-YL)hexyl]-1,8-naphthyridin-2-(1H)-one, SC-44368, a Potent Anti-aggregatory Agent which Selectively Inhibits Platelet Cyclic AMP Phosphodiesterase Platelets ·R. F. G. Booth,Paul W. Manley,S Buckham,David G. Hassall,A C Honey,N. Lad,David O. Lunt,Sarah Oswald,Roderick A. Porter,David P. Tuffin	1992	7
12	Three probe flow cytometry of a human foam‐cell forming macrophage Cytometry ·David G. Hassall	1992	21
13	Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arteriosclerosis and Thrombosis A Journal of Vascular Biology ·Philip M. Bath,David G. Hassall,A. M. Gladwin,Richard Palmer,J. F. MARTIN	1991	276
14	CD11/CD18 cell surface adhesion glycoproteins: Discordance of monocyte function and expression in response to stimulation Experimental Cell Research ·David G. Hassall,Philip M. Bath,A-M. Gladwin,Julian E. Beesley	1991	4
15	Detection of a Protein in Human Platelet Membranes which Binds Low-density Lipoproteins Platelets ·David G. Hassall,Kalpna Desai,James S. Owen,K. Richard Bruckdorfer	1990	23
16	MAC-1 mediates adherence of human monocytes to endothelium via a protein kinase C dependent mechanism Biochimica et Biophysica Acta (BBA) - Molecular Cell Research ·Ann-Marie Gladwin,David G. Hassall,John F. Martin,R. F. G. Booth	1990	23
17	Monocyte-lymphocyte discrimination in a new microtitre-based adhesion assay Journal of Immunological Methods ·Philip M. Bath,R. F. G. Booth,David G. Hassall	1989	55
18	The Increased Sensitivity of Platelets to Prostacyclin in Marathon Runners Thrombosis and Haemostasis ·C. J. Dix,David G. Hassall,K. Richard Bruckdorfer	1984	9
19	The effect of low-density lipoproteins on the synthesis of cyclic nucleotides induced by prostacyclin in isolated platelets Biochemical Journal ·K. Richard Bruckdorfer,S. Buckley,David G. Hassall	1984	25
20	Hypocholesterolaemia and non-cardiovascular disease: metabolic studies on subjects with low plasma cholesterol concentrations. BMJ ·C B Marenah,Basil S. Lewis,David G. Hassall,A. La Ville,Claudio Cortese,W. D. Mitchell,K. R. Bruckdorfer,B Slavin,N.E. Miller,Peter Turner,E Heduan	1983	25

About David G. Hassall

David G. Hassall is a scholar working on Biochemistry, Immunology and Allergy and Immunology, having authored 34 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cholesterol and Lipid Metabolism (7 papers), Peroxisome Proliferator-Activated Receptors (7 papers), Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Lipoproteins and Cardiovascular Health (5 papers), Atherosclerosis and Cardiovascular Diseases (5 papers), Adipose Tissue and Metabolism (4 papers), Cell Adhesion Molecules Research (3 papers) and Cardiovascular Disease and Adiposity (2 papers). The work is most often cited by research in Biochemistry (165 citations), Endocrinology, Diabetes and Metabolism (337 citations) and Biochemistry (118 citations). David G. Hassall has collaborated with scholars based in United Kingdom, United States and France. Frequent co-authors include K. Richard Bruckdorfer, Philip M. Bath, R. F. G. Booth, James S. Owen, A. M. Gladwin, Richard Palmer, J. F. MARTIN, Julian E. Beesley, A C Honey and John F. Martin. Their work appears in journals such as Journal of Biological Chemistry, Advanced Drug Delivery Reviews and Biochemical Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact